VIZSLA SILVER HOSTS IN-DEPTH TECHNICAL OVERVIEW OF ITS RECENT FEASIBILITY STUDY AND CONVERTIBLE OFFERING
Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial